Clario, a leading provider of endpoint data solutions to the clinical trial industry, announces they have acquired NeuroRx, a leader in imaging analysis with expertise in multiple sclerosis. NeuroRx has built a reputation for providing clinical trials with a comprehensive suite of imaging-related services—from protocol assistance to the interpretation and reporting of data. They have supported the approvals of numerous neurological therapies, including 12 FDA-approved multiple-sclerosis drugs since 2011. In addition to the NeuroRx acquisition, Clario last week announced a signed definitive agreement to acquire WCG’s eCOA business.
Read the full article: Clario Announces Acquisition of Imaging Provider NeuroRx //
Source: https://www.prnewswire.com/news-releases/clario-announces-acquisition-of-imaging-provider-neurorx-302403082.html